免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Hemoblock_S(藥品);Hemoblock_S(OTC)

K 號:K232216 · 2024-04-19

決定日期2024-04-19
產品代碼QSY
決定相當於

器材摘要

Hemoblock_S (Prescription); Hemoblock_S (OTC) is the device name listed in this FDA 510(k) record. The listed applicant is Incore Co., Ltd.. It received FDA 510(k) clearance on 2024-04-19 under 510(k) number K232216. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

常見問題

What is the Hemoblock_S (Prescription); Hemoblock_S (OTC)?

Hemoblock_S (Prescription); Hemoblock_S (OTC) is a medical device that received FDA 510(k) clearance on 2024-04-19. The listed applicant is Incore Co., Ltd.. The 510(k) number is K232216.

When did Hemoblock_S (Prescription); Hemoblock_S (OTC) receive FDA 510(k) clearance?

Hemoblock_S (Prescription); Hemoblock_S (OTC) received FDA 510(k) clearance on 2024-04-19, under 510(k) number K232216.

Who is the listed applicant for Hemoblock_S (Prescription); Hemoblock_S (OTC)?

The FDA 510(k) record lists Incore Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Hemoblock_S (Prescription); Hemoblock_S (OTC)?

The FDA product code for Hemoblock_S (Prescription); Hemoblock_S (OTC) is QSY.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Incore Co., Ltd. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:QSY)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑